Visual hallucinations are associated with lower αbungarotoxin binding in dementia with Lewy bodies
暂无分享,去创建一个
E. Perry | P. Lantos | N. Cairns | C. Ballard | R. Perry | E. Jaros | M. Piggott | J. Court | M. Johnson | M Johnson | N Cairns | P Lantos | J. A Court | E. K Perry | E Jaros | C. G Ballard | M. A Piggott | J. T O'Brien | C Holmes | R. H Perry | C. Holmes | J. O’Brien
[1] L. Schneider,et al. Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease. , 1994, Archives of neurology.
[2] I. McKeith,et al. Neuroleptic sensitivity to risperidone in Lewy body dementia , 1995, The Lancet.
[3] A. Nordberg,et al. Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain. , 1999, Brain research. Molecular brain research.
[4] E. Perry,et al. Nigrostriatal dopaminergic activities in dementia with lewy bodies in relation to neuroleptic sensitivity: comparisons with parkinson’s disease , 1998, Biological Psychiatry.
[5] K Ugurbil,et al. Activation of visuomotor systems during visually guided movements: a functional MRI study. , 1998, Journal of magnetic resonance.
[6] M. Hutchinson,et al. Cholinesterase inhibition in Parkinson's disease. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[7] D. Bass,et al. Symptoms of mental impairment among elderly adults and their effects on family caregivers. , 1986, Journal of gerontology.
[8] E. Perry,et al. Delusions associated with elevated muscarinic binding in dementia with Lewy bodies , 2000, Annals of neurology.
[9] Hans Förstl,et al. Psychotic features and the course of Alzheimer's disease: relationship to cognitive, electroencephalographic and computerized tomography findings , 1993, Acta psychiatrica Scandinavica.
[10] Agneta Nordberg,et al. Neuronal nicotinic receptors in the human brain , 2000, Progress in Neurobiology.
[11] D. Bennett,et al. Hallucinations and associated factors in Alzheimer's disease. , 1991, The Journal of neuropsychiatry and clinical neurosciences.
[12] H. Haeske-Dewick. Hallucinations in Parkinson's disease: Characteristics and associated clinical features , 1995 .
[13] Abraham Weizman,et al. Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease. , 1996, Advances in neurology.
[14] L Kruglyak,et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Moossy,et al. Neuropathologic and neurochemical correlates of psychosis in primary dementia. , 1991, Archives of neurology.
[16] Wayne C. Drevets,et al. Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type , 1989, Biological Psychiatry.
[17] R. H. Perry,et al. Acetylcholine and Hallucinations - Disease-Related Compared to Drug-Induced Alterations in Human Consciousness , 1995, Brain and Cognition.
[18] G. Wilcock,et al. The prevalence and phenomenology of psychotic symptoms in dementia sufferers , 1995 .
[19] J. Copeland,et al. Computerized diagnosis from a standardized history schedule: A preliminary communication about the organic section of the HAS–AGECAT system , 1992 .
[20] D. Jeste,et al. A Study of Delusions in a Large Cohort of Alzheimer's Disease Patients. , 1994, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[21] J. Changeux,et al. Identification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice , 1998, The Journal of Neuroscience.
[22] E. Perry,et al. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson’s disease and Alzheimer’s disease and in relation to neuroleptic medication , 2000, Neuroscience.
[23] A. Kurz,et al. DELUSIONS AND HALLUCINATIONS IN ALZHEIMER'S DISEASE: RESULTS FROM A TWO‐YEAR LONGITUDINAL STUDY , 1996 .
[24] E. Perry,et al. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. , 1999, The American journal of psychiatry.
[25] B. Gulanski,et al. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease , 1998, Neurology.
[26] D. Benson,et al. Dementia: A Clinical Approach , 1983 .
[27] P. Riederer,et al. Human post-mortem striatal α4β2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome , 2000, Neuroscience Letters.
[28] A. Owen,et al. Psychiatric, neurological and medical aspects of misidentification syndromes: a review of 260 cases , 1991, Psychological Medicine.
[29] E. Perry,et al. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. , 1992, BMJ.
[30] K. Marder,et al. The Columbia University Scale for Psychopathology in Alzheimer's disease. , 1992, Archives of neurology.
[31] G. Zubenko,et al. Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease , 1991, Biological Psychiatry.
[32] J. Grace,et al. Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease , 1998, The Lancet.
[33] K. Kosaka,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.
[34] G. Stebbins,et al. Intravenous levodopa in hallucinating Parkinson's disease patients , 1998, Neurology.
[35] L. Thal,et al. Nicotinic receptor losses in dementia with Lewy bodies: comparisons with Alzheimer’s disease , 2000, Neurobiology of Aging.
[36] P. Ince,et al. The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies , 1997, Acta neurologica Scandinavica.
[37] J. O'Brien,et al. A Prospective Study of Psychotic Symptoms in Dementia Sufferers: Psychosis in Dementia , 1997, International Psychogeriatrics.
[38] R. Kerwin,et al. Neuronal Nicotinic Receptors in Dementia with Lewy Bodies and Schizophrenia , 1999, Journal of neurochemistry.
[39] E. Perry,et al. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use , 1998, Neuroscience.
[40] M. Skaff,et al. Caregiving and the stress process: an overview of concepts and their measures. , 1990, The Gerontologist.
[41] E. Perry,et al. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types , 1990, Journal of neural transmission. Parkinson's disease and dementia section.
[42] Mrinalini Honavar,et al. Lewy bodies and response to tacrine in Alzheimer's disease , 1994, The Lancet.
[43] P V Rabins,et al. The impact of dementia on the family. , 1982, JAMA.
[44] R Freedman,et al. Nicotinic receptor function in schizophrenia. , 1996, Schizophrenia bulletin.
[45] Robert H. Perry,et al. Senile dementia of Lewy body type A clinically and neuropathologically distinct form of Lewy body dementia in the elderly , 1990, Journal of the Neurological Sciences.
[46] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[47] R. Howard,et al. Donepezil for the treatment of psychosis in dementia with Lewy bodies , 2000, International journal of geriatric psychiatry.
[48] K. Blennow,et al. Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. , 1999, Neuroreport.
[49] R. Freedman,et al. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia , 1995, Biological Psychiatry.
[50] G A Chase,et al. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. , 1990, The American journal of psychiatry.
[51] D. Irving,et al. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology , 1995, Neuroscience.
[52] K. Rockwood,et al. Donepezil for Treatment of Dementia With Lewy Bodies: A Case Series of Nine Patients , 1998, International Psychogeriatrics.
[53] F. Huppert,et al. CAMDEX: A Standardised Instrument for the Diagnosis of Mental Disorder in the Elderly with Special Reference to the Early Detection of Dementia , 1986, British Journal of Psychiatry.
[54] E. Perry,et al. Evidence of a Monoaminergic‐Cholinergic Imbalance Related to Visual Hallucinations in Lewy Body Dementia , 1990, Journal of neurochemistry.
[55] A. Burns,et al. Psychiatric Phenomena in Alzheimer's Disease. I: Disorders of Thought Content , 1990, British Journal of Psychiatry.
[56] P. Clarke. The fall and rise of neuronal α-bungarotoxin binding proteins , 1992 .